Cambridge, Massachusetts 02142


Purpose:

The objective is to track pregnancy outcomes in women with Pompe Disease and to follow infants born to women with Pompe Disease.


Study summary:

Study Design Time Perspective: Retrospective and Prospective


Criteria:

Inclusion Criteria: - Enroll in or agree to enroll in Pompe Registry - Be pregnant or have been pregnant with appropriate medical documentation - Provide a signed Patient Information and Authorization Form to participate in the sub-registry prior to any sub-registry related data collection is performed Exclusion Criteria: - No Exclusion Criteria


NCT ID:

NCT00567073


Primary Contact:

Study Director
Medical Monitor
Genzyme, a Sanofi Company

Medical Information
Phone: 800-745-4447
Email: MedInfo@genzyme.com


Backup Contact:

Email: MedInfo@genzyme.com
Medical Information
Phone: 617-252-7832


Location Contact:

Cambridge, Massachusetts 02142
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.